Madrigal pharmaceuticals to release fourth-quarter and full-year 2024 financial results and host webcast on february 26, 2025

Conshohocken, pa., feb. 12, 2025 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq: mdgl) announced today that it will release its fourth-quarter and full-year 2024 financial results on wednesday, feb. 26, 2025, prior to the open of the u.s. financial markets.

MDGL Ratings Summary

MDGL Quant Ranking